glp-1 parkinson's disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular and neurodegenerative disorders GLP-1 Receptor Agonists in Neurodegeneration:

We set it as an absolute difference of 0.1% between groups, which is more conservative than the difference found in previous trials 20

ceramide-rich creams and ointments work better than lotions for GLP-1 patients losing weight rapidly

Micheles podcast, Ageless and Timeless, was one of 20 Inaugural Podcasts selected for the Muscle and Fitness Plus platform that began in 2023

In the UK, buying and injecting B12 yourself is strongly advised against

Patients should report ongoing gastrointestinal symptoms, signs of dehydration, or thirst that seems disproportionate to fluid intake

A: Visible improvement usually starts after 4 weeks of consistent use